SFX by Ex Libris Inc.

Title:	Bacterial Sliding Clamp Inhibitors that Mimic the Sequential Binding Mechanism of Endogenous Linear Motifs
Source:	Journal of Medicinal Chemistry [0022-2623] yr:2015

Basic

Full text

Full text available via American Chemical Society Journals

Year:

Volume:

Issue:

Start Page:

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Joseph McCarthy, D. "Fragment-Based Lead Discovery and Design." Journal of chemical information and modeling 54.3 (2014): 693-704.
description	2.	Scott, Duncan E. "Fragment-based approaches in drug discovery and chemical biology." Biochemistry 51.25 (2012): 4990-5003.
description	3.	Rees David C, David C. "Fragment-based lead discovery." Nature reviews. Drug discovery 3.8 (2004): 660-672.
description	4.	Scott, D. "Using a Fragment-Based Approach To Target Protein-Protein Interactions." ChemBioChem 14.3 (2013): 332-42.
description	5.	Badger, J. "Structure determination of LpxA from the lipopolysaccharide-synthesis pathway of Acinetobacter baumannii." Acta crystallographica. Section F 69.1 (2012): 1477-1481.
description	6.	Erlanson, Daniel A. "Introduction to Fragment-Based Drug Discovery." Top Curr Chem 317.Fragment-Based Drug Discovery and X-Ray Crystallography (2011): 1-32.
description	7.	Murray, C. "The rise of fragment-based drug discovery." Nature Chemistry 1.3 (2009): 187-192.
description	8.	Erlanson, Daniel A A. "Fragment-based drug discovery." Journal of medicinal chemistry 47.14 (2004): 3463-3482.
description	9.	Murray, C. "Experiences in fragment-based drug discovery." Trends in pharmacological sciences 33.5 (2012): 224-32.
description	10.	Zartler, M. "Introduction to Fragment-Based Drug Discovery." 2008. 1-13.
description	11.	Kohlmann, A. "Fragment Growing and Linking Lead to Novel Nanomolar Lactate Dehydrogenase Inhibitors." Journal of medicinal chemistry 56.3 (2013): 1023-1040.
description	12.	Petros, A. "Fragment-Based Drug Discovery: A Practical Approach." Journal of the American Chemical Society 131.16 (2009): 6036-6036.
description	13.	Zartler, E. "Practical aspects of using NMR in fragment-based screening." Fragment-based drug discovery : 2008.
description	14.	ANTONYSAMY, Stephen S. "Fragment-based discovery of hepatitis C virus NS5b RNA polymerase inhibitors." Bioorganic & medicinal chemistry letters 18.9 (2008): 2990-282.
description	15.	Carr, Robin A. "Fragment-based lead discovery: leads by design." Drug discovery today 10.14 (2005): 987-92.
description	16.	ZHAO, H. "Scaffold selection and scaffold hopping in lead generation: a medicinal chemistry perspective." Drug discovery today 12.3 (2007): 149-155.
description	17.	Zartler, Edward R R. "Fragonomics: fragment-based drug discovery." Current opinion in chemical biology 9.4 (2005): 366-370.
description	18.	Lopez Mendez, B. "Ligand-detected F-19 NMR-based fragment screening for drug discovery against selected macromolecular targets." The FEBS journal 2012. 540-541.
description	19.	Winter, A. "Biophysical and computational fragment-based approaches to targeting protein-protein interactions: Applications in structure-guided drug discovery." Quarterly reviews of biophysics 45.4 (2012): 383-426.
description	20.	Freigang, S. "Transport and uptake of immunogenic lipids." Molecular immunology 55.2 (2012): 179-81.